Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (4)
  • 2024 (1)
  • 2023 (4)
  • 2022 (6)
  • 2021 (1)

Subject

  • Drug Trafficking (92)
  • Guilty Plea (38)
  • Guns/Weapons (37)
  • Arrests/Convictions - Major (30)
  • Synthetic drugs (29)
  • HIDTA (27)
  • Prescription Drugs (25)
  • Take Back Day (24)
  • Gangs (22)
  • OCDETF/Task Force (20)
  • Task Forces/Task Force Officers (19)
  • Fake Pills (18)
  • Seizures (Drugs/Property) (18)
  • Diversion Division (16)
  • Fentanyl Awareness (15)
  • Money Laundering (13)
  • Major Law Enforcement Operation (10)
  • Overdose (6)
  • Press Conferences (6)
  • International/Foreign Operations (4)
  • Prevention/Education - DEA websites GSAD, JTT etc (4)
  • Dark Web- Internet Trafficking (3)
  • One Pill Can Kill (3)
  • Outreach/Drug Prevention (3)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Extraditions (2)
  • Campaigns (1)
  • Congressional Affairs (1)
  • Fentanyl Free America (1)
  • Intergovernmental Affairs (1)
  • Narcoterrorism (1)
  • Red Ribbon (1)
  • Terrorism (1)
  • Pharmaceuticals/Pharmacists/Physicians (16)

Drug Name

  • Oxycodone (2)

Field Division

  • Washington, DC (35)
  • St. Louis (32)
  • New York (21)
  • Chicago (19)
  • Miami (16)
  • Atlanta (12)
  • El Paso (9)
  • Headquarters (9)
  • Dallas (8)
  • Houston (7)
  • San Francisco (7)
  • Seattle (7)
  • New England (5)
  • San Diego (5)
  • Los Angeles (4)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
  • New Jersey (11)
  • Louisville (5)
Clear All Results
PRESS RELEASE

Clay County Pharmacy Investigation and Prosecution Ends in Guilty Pleas

September 11, 2025
NASHVILLE – Thomas K. Weir, 65, majority owner of Oakley Pharmacy d/b/a Dale Hollow Pharmacy and Clay County Xpress Pharmacy (“Xpress Pharmacy”); William L. Donaldson, 65, former owner and pharmacist of Dale Hollow Pharmacy (then known as Donaldson Pharmacy); and Pamela Spivey, 55, co-owner of Xpress Pharmacy (all of Celina...
September 11, 2025
PRESS RELEASE

Putnam County Veterinarian Ordered to Pay $956,709 in Civil Penalties

August 07, 2025
CHARLESTON, W.Va. – The United States Attorney’s Office for the Southern District of West Virginia secured a $956,709 default judgment against Clara Ann Mason, a Putnam County veterinarian, after she was unable to account for 9,796 dosage units of oxycodone HCL, hydrocodone/acetaminophen and other controlled substances, Acting United States Attorney...
August 07, 2025
PRESS RELEASE

Franklin, Kentucky Pharmacist and Spouse Sentenced to Federal Prison

May 06, 2025
Louisville, KY – Last week, a Franklin, Kentucky, pharmacist was sentenced to 3 years in federal prison and his wife was sentenced to 2 years in federal prison for engaging in a conspiracy to commit theft of medical products, conspiracy to unlawfully distribute controlled substances, conspiracy to commit health care...
May 06, 2025
PRESS RELEASE

Three Convicted for Fraudulently Billing Over $8 Million to Medicare and Medicaid Through Opioid Addiction Treatment Clinics in Kentucky

March 24, 2025
A federal jury convicted a Kentucky doctor, a Texas businessman, and a Kentucky woman for their roles operating a scheme out of a series of addiction treatment facilities in Kentucky that fraudulently billed Medicare and Kentucky Medicaid for over $8 million. The verdict was handed down on Thursday, March 20...
March 24, 2025
PRESS RELEASE

Drug Manufacturer to Pay $2.25 Million to Settle Substances Act Allegations

April 10, 2024
NEWARK, N.J. – A pharmaceutical manufacturer agreed to pay $2.25 million to resolve allegations that it violated the Controlled Substances Act (CSA), DEA New Jersey Field Division Special Agent in Charge Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced today The manufacturer, Novel Laboratories Inc. (Novel), a subsidiary of...
April 10, 2024
PRESS RELEASE

Passaic County Doctor Charged in Conspiracy to Distribute Opioids

October 04, 2023
NEWARK, N.J. – A Passaic County, New Jersey, doctor was charged with conspiring to distribute opioids without a legitimate medical reason, Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Field Division Cheryl Ortiz and U.S. Attorney Philip R. Sellinger announced. Lisa Ferraro, 65, of Hillsdale, New...
October 04, 2023
PRESS RELEASE

Toms River Woman Charged with Unauthorized Practice of Medicine, Forgery, Health Care Claims Fraud, and Distribution of a Controlled Dangerous Substance

July 27, 2023
NEWARK, N.J. – Special Agent in Charge of the Drug Enforcement Administration’s (DEA) New Jersey Division Cheryl Ortiz and Ocean County Prosecutor Bradley D. Billhimer announced that on July 25, 2023, Maria F. Macburnie, aka Marife L. Macburnie, 62, of Toms River, was charged with Practicing Medicine by an Unlicensed...
July 27, 2023
PRESS RELEASE

DEA to host summit on Medication for Opioid Use Disorder (MOUD) in Charleston, WV

April 04, 2023
Louisville, Ky. – The Drug Enforcement Administration (DEA) and the State of West Virginia are hosting a discussion on Medication for Opioid Use Disorder (MOUD) in Charleston, West Virginia on Saturday, April 15, 2023 from 12:00 p.m. to 5:00 p.m. The event will take place at the University of Charleston’s...
April 04, 2023
PRESS RELEASE

Former Office Manager of New Jersey Medical Practice Admits Conspiring with Doctor to Divert Controlled Substances

February 15, 2023
NEWARK, N.J. – Acting Special Agent in Charge of the Drug Enforcement Administration’s New Jersey Division Daniel J. Kafafian and U.S. Attorney for the District of New Jersey Philip R. Sellinger announced a former office manager of a New Jersey medical practice admitted conspiring with the doctor who owned the...
February 15, 2023
PRESS RELEASE

Department of Justice Files Nationwide Lawsuit Against Amerisource Bergen Corp. and Subsidiaries for Controlled Substances Act Violations

December 29, 2022
NEWARK, N.J. – In a civil complaint filed today, the Department of Justice alleges that AmerisourceBergen Corp. and two of its subsidiaries, AmerisourceBergen Drug Corp. and Integrated Commercialization Solutions LLC (AmerisourceBergen), collectively one of the country’s largest wholesale pharmaceutical distributors and one of the largest companies in America by revenue...
December 29, 2022
Showing 1 - 10 of 16 results

Pagination

  • Current page 1
  • Page 2
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster